Elham Zeinalzadeh

776 total citations
19 papers, 557 citations indexed

About

Elham Zeinalzadeh is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Elham Zeinalzadeh has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Elham Zeinalzadeh's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Medical and Biological Ozone Research (3 papers). Elham Zeinalzadeh is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Medical and Biological Ozone Research (3 papers). Elham Zeinalzadeh collaborates with scholars based in Iran, Azerbaijan and Italy. Elham Zeinalzadeh's co-authors include Hossein Samadi Kafil, Khudaverdi Ganbarov, Ehsaneh Khodadadi, Mohammad Asgharzadeh, Sounkalo Dao, Parham Maroufi, Silvano Esposito, Mehdi Yousefi, Isabella Esposito and Şükran Köse and has published in prestigious journals such as SHILAP Revista de lepidopterología, Mutation research. Fundamental and molecular mechanisms of mutagenesis and Evidence-based Complementary and Alternative Medicine.

In The Last Decade

Elham Zeinalzadeh

19 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Zeinalzadeh Iran 12 178 171 82 62 39 19 557
Carlos Barba‐Ostria Ecuador 14 290 1.6× 247 1.4× 63 0.8× 49 0.8× 30 0.8× 32 865
Mohammad A. I. Al-Hatamleh Malaysia 14 166 0.9× 337 2.0× 77 0.9× 41 0.7× 94 2.4× 38 922
Sounkalo Dao Mali 13 210 1.2× 246 1.4× 60 0.7× 44 0.7× 47 1.2× 51 781
Manon Boxberger France 9 135 0.8× 349 2.0× 41 0.5× 87 1.4× 23 0.6× 27 727
Angus Nnamdi Oli Nigeria 15 250 1.4× 158 0.9× 81 1.0× 25 0.4× 37 0.9× 69 838
Mahdi Asghari Ozma Iran 14 314 1.8× 155 0.9× 231 2.8× 42 0.7× 20 0.5× 29 656
Gerco den Hartog Netherlands 17 219 1.2× 387 2.3× 49 0.6× 37 0.6× 66 1.7× 61 1.0k
Abdelaziz Elgaml Egypt 18 330 1.9× 291 1.7× 44 0.5× 115 1.9× 89 2.3× 42 858
G Sridharan India 16 120 0.7× 147 0.9× 84 1.0× 26 0.4× 23 0.6× 39 605

Countries citing papers authored by Elham Zeinalzadeh

Since Specialization
Citations

This map shows the geographic impact of Elham Zeinalzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Zeinalzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Zeinalzadeh more than expected).

Fields of papers citing papers by Elham Zeinalzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Zeinalzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Zeinalzadeh. The network helps show where Elham Zeinalzadeh may publish in the future.

Co-authorship network of co-authors of Elham Zeinalzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Zeinalzadeh. A scholar is included among the top collaborators of Elham Zeinalzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Zeinalzadeh. Elham Zeinalzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Najafi, Fatemeh, et al.. (2022). Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 824. 111776–111776. 23 indexed citations
2.
Khodadadi, Ehsaneh, Elham Zeinalzadeh, Mohammad Asgharzadeh, et al.. (2021). A Comprehensive Study on the Antimicrobial Properties of Resveratrol as an Alternative Therapy. Evidence-based Complementary and Alternative Medicine. 2021. 1–15. 52 indexed citations
3.
Kafil, Hossein Samadi, Mahdi Asghari Ozma, Ehsaneh Khodadadi, et al.. (2021). Bacterial Proteomics and its Application in Pathogenesis Studies. Current Pharmaceutical Biotechnology. 23(10). 1245–1256. 13 indexed citations
4.
Rahman, Heshu Sulaiman, Marwah Suliman Maashi, Svetlana Danshina, et al.. (2021). MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers. Genes & Diseases. 9(4). 849–867. 25 indexed citations
5.
Ghasemi, Negin, et al.. (2020). Antibacterial Properties of Aloe vera on Intracanal Medicaments against Enterococcus faecalis Biofilm at Different Stages of Development. International Journal of Dentistry. 2020. 1–6. 29 indexed citations
6.
Gholizadeh, Pourya, Elham Zeinalzadeh, Pasquale Pagliano, et al.. (2020). <p>Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)</p>. Journal of Inflammation Research. Volume 13. 285–292. 38 indexed citations
7.
Khodadadi, Ehsaneh, Parham Maroufi, Ehsan Khodadadi, et al.. (2020). Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19). Microbial Pathogenesis. 146. 104241–104241. 48 indexed citations
8.
Fathizadeh, Hadis, Sepehr Taghizadeh, Khudaverdi Ganbarov, et al.. (2020). Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19. Microbial Pathogenesis. 149. 104556–104556. 28 indexed citations
9.
Maroufi, Parham, Ehsaneh Khodadadi, Elham Zeinalzadeh, et al.. (2020). SARS-CoV-2 receptor ACE2 and molecular pathway to enter target cells during infection. 33(1). e105–e113. 9 indexed citations
10.
Khodadadi, Ehsaneh, Elham Zeinalzadeh, Sepehr Taghizadeh, et al.. (2020). <p>Proteomic Applications in Antimicrobial Resistance and Clinical Microbiology Studies</p>. Infection and Drug Resistance. Volume 13. 1785–1806. 19 indexed citations
11.
Ozma, Mahdi Asghari, Parham Maroufi, Ehsaneh Khodadadi, et al.. (2020). Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.. PubMed. 28(2). 153–165. 113 indexed citations
12.
Eslami, Hosein, et al.. (2019). Photodynamic therapy of infection in burn patients. Reviews in Medical Microbiology. 30(4). 228–239. 4 indexed citations
13.
Gholizadeh, Pourya, Ali Pormohammad, Mojtaba Varshochi, et al.. (2018). Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease. Microbial Pathogenesis. 127. 48–55. 91 indexed citations
14.
Pourlak, Tala, et al.. (2018). Etiological Agents of Pediatric Diarrhea in Ardebil, Northwestern Iran. Archives of Pediatric Infectious Diseases. In Press(In Press). 3 indexed citations
15.
Eslami, Hosein, et al.. (2017). Synergistic effect of persica mouthwash and Iranian ethanolic extract of propolis against biofilm formation of oral pathogens (in vitro study). SHILAP Revista de lepidopterología. 58(4). 155–161. 2 indexed citations
16.
Pourlak, Tala, Mohammad Yousef Memar, Naser Alizadeh, et al.. (2017). Thymol and carvacrol strongly inhibit biofilm formation and growth of carbapenemase-producing Gram negative bacilli. Cellular and Molecular Biology. 63(5). 108–112. 52 indexed citations
17.
18.
Leylabadlo, Hamed Ebrahimzadeh, et al.. (2016). Malassezia species infection of the synovium after total knee arthroplasty surgery. SHILAP Revista de lepidopterología. 11. Doc19–Doc19. 6 indexed citations
19.
Taghavi, Seyed Alireza, et al.. (2016). Comparing Antimicrobial Effect of CO2 Laser with Halita in Oral Infection Control. Biomedical & Pharmacology Journal. 9(2). 787–791. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Barba‐Ostria Breakdown of academic impact, for papers by Mohammad A. I. Al-Hatamleh Breakdown of academic impact, for papers by Sounkalo Dao Breakdown of academic impact, for papers by Manon Boxberger Breakdown of academic impact, for papers by Angus Nnamdi Oli Breakdown of academic impact, for papers by Mahdi Asghari Ozma Breakdown of academic impact, for papers by Gerco den Hartog Breakdown of academic impact, for papers by Abdelaziz Elgaml Breakdown of academic impact, for papers by G Sridharan
Rankless by CCL
2026